Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics launches new genetic diagnostic test for gastric cancer

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

GI Company's Phase II study demonstrates safety of rhITF oral spray formulation

GI Company's Phase II study demonstrates safety of rhITF oral spray formulation

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Hospira launches generic version of Sanofi-Aventis' Eloxatin

Hospira launches generic version of Sanofi-Aventis' Eloxatin

Cost effectiveness study looks at potential value of new genetic test for guiding chemotherapy treatment

Cost effectiveness study looks at potential value of new genetic test for guiding chemotherapy treatment

Topical fluorouracil may improve appearance of aging skin

Topical fluorouracil may improve appearance of aging skin

Gene variation associated with resistance to chemotherapy drug in women with breast cancer

Gene variation associated with resistance to chemotherapy drug in women with breast cancer

Study shows that induction chemotherapy prior to chemoradiotherapy significantly increases time-to-treatment failure in comparison to standard chemoradiotherapy alone

Study shows that induction chemotherapy prior to chemoradiotherapy significantly increases time-to-treatment failure in comparison to standard chemoradiotherapy alone

DNA protecting protein helps cancer drug to kill cells

DNA protecting protein helps cancer drug to kill cells

Gene alterations associated with response to anthracycline therapy for breast cancer

Gene alterations associated with response to anthracycline therapy for breast cancer

Brain metastases hijack neuron-supporting cells to resist chemotherapy

Brain metastases hijack neuron-supporting cells to resist chemotherapy

3-drug chemotherapy combo increases organ preservation in patients with larynx cancer

3-drug chemotherapy combo increases organ preservation in patients with larynx cancer

Sequential and alternating chemotherapy and radiation equally effective in larynx cancer therapy

Sequential and alternating chemotherapy and radiation equally effective in larynx cancer therapy

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Benefits of combined treatments against cancer

Benefits of combined treatments against cancer

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

Experimental chemo shows promise in treating advanced non-small cell lung cancer

Experimental chemo shows promise in treating advanced non-small cell lung cancer

Chemo and radiation after surgery prolongs life for pancreatic cancer patients

Chemo and radiation after surgery prolongs life for pancreatic cancer patients

Cisplatin found to be less effective than standard treatment for patients with anal cancer

Cisplatin found to be less effective than standard treatment for patients with anal cancer